Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

The Prognostic Lung Fibrosis Consortium (PROLIFIC), a collaborative consortium advancing biomarker tools for pulmonary fibrosis (PF) research, announced today that the PROLIFIC Risk Score has been ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

Identifying and verifying biomarkers to improve access to diagnosis for FTD is a critical gap in clinical care. Diagnosis for FTD takes significantly longer than many other neurodegenerative disorders ...

For centuries, the field of pathology has been defined by a single instrument: the microscope. But according to William ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

FDA NDI Acknowledgment And Korean MFDS Approval For HB05P Muscle Health Ingredient. Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ...

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in  patients with an aggressive ...

Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience ...

The IAEA profiles employees to provide insight into the variety of career paths that support the Agency’s mission of Atoms for Peace and Development and to inspire and encourage readers, particularly ...

A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...